Zobrazeno 1 - 10
of 626
pro vyhledávání: '"Vin‐Cent Wu"'
Autor:
Jia-Yuh Sheu, Li-Yang Chang, Jui-Yi Chen, Heng-Chih Pan, Chi-Shin Tseng, Jeff S. Chueh, Vin-Cent Wu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) have demonstrated efficacy in reducing cardiovascular events and potentially improving kidney function in diabetic patients. This investigation analyzes the TriNetX database to assess the e
Externí odkaz:
https://doaj.org/article/0664842451394b78a95a49ac5f1a6931
Autor:
Chu-Wen Fang, Hui-Lung Hsieh, Shuo-Meng Wang, Kuo-How Huang, Kang-Yung Peng, Yen-Hung Lin, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Primary aldosteronism (PA), which is present in 5–18% of hypertensive patients, is a leading cause of secondary hypertension. Adrenalectomy is often recommended for patients with unilateral primary aldosteronism (uPA), yielding
Externí odkaz:
https://doaj.org/article/d5b86ea7c9c349c098f7c959c6a641fd
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have demonstrated associations with lowering cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, the impact of SGLT-2is on individuals at dialysis
Externí odkaz:
https://doaj.org/article/91fe516990dd466b9cacda6ba383245c
Autor:
Szu-Yu Pan, Thomas Tao-Min Huang, Yi-Chan Lin, Hui-Ting Liu, Sheng-Chieh Chou, Chih-Yuan Lee, Chien-Chia Chen, Chuan-Hsiu Fu, Chi-Chao Chao, Vin-Cent Wu
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 8, Pp 899-903 (2024)
Background/Purpose: Double-filtration plasmapheresis (DFPP) can be used to remove circulating pathogenic molecules. By reclaiming filtered albumin, DFPP reduces the need for albumin and plasma replacement. Large proteins, such as fibrinogen, are remo
Externí odkaz:
https://doaj.org/article/2d6b4d7df250458397fe7560e4b9fbc0
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) have demonstrated efficacy in improving mortality and cardiovascular (CV) outcomes. However, the impact of GLP-1RAs therapy on cardiorenal outcomes of diabetic patients at the c
Externí odkaz:
https://doaj.org/article/c13e2393f5194c9db441d7d387d78f58
Autor:
Szu-Yu Pan, Thomas Tao-Min Huang, Zheng-Hong Jiang, Li-Chun Lin, I-Jung Tsai, Tsung-Lin Wu, Chih-Yi Hsu, Ting Wang, Hui-Chuen Chen, Yu-Feng Lin, Vin-Cent Wu
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 4, Pp 406-416 (2024)
Acute kidney disease (AKD) is a critical transitional period between acute kidney injury and chronic kidney disease. The incidence of AKD following acute kidney injury is approximately 33.6%, and it can occur without identifiable preceding acute kidn
Externí odkaz:
https://doaj.org/article/593314c8fba84dd5a869171cbb8d14ac
Autor:
Kun-Mo Lin, Ching-Chun Su, Jui-Yi Chen, Szu-Yu Pan, Min-Hsiang Chuang, Cheng-Jui Lin, Chih-Jen Wu, Heng-Chih Pan, Vin-Cent Wu
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 4, Pp 393-405 (2024)
Traditional acute kidney injury (AKI) classifications, which are centered around semi-anatomical lines, can no longer capture the complexity of AKI. By employing strategies to identify predictive and prognostic enrichment targets, experts could gain
Externí odkaz:
https://doaj.org/article/c59520ca3a5149698c1baacc5ca8d73e
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 4, Pp 548-558 (2024)
Background The Acute Disease Quality Initiative advocates multidisciplinary care for the survivors of acute kidney injury (AKI). The bundled care strategy recognizes the role of pharmacists. However, their specific contributions in this context remai
Externí odkaz:
https://doaj.org/article/f98143c7e5a245d6b664e004577bcedd
Autor:
Heng-Chih Pan, Jui-Yi Chen, Hsing-Yu Chen, Fang-Yu Yeh, Chiao-Yin Sun, Thomas Tao-Min Huang, Vin-Cent Wu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Previous studies have explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing cardiovascular events in type 2 diabetes. Here we show that GLP-1 RAs are associated with lower risks of mortality, major cardiov
Externí odkaz:
https://doaj.org/article/af1e9e6c27d6458baada297ce5415143
Autor:
Chu-Wen Fang, Chi-Shin Tseng, Kang-Yung Peng, Vin-Cent Wu, Shuo-Meng Wang, Kuo-How Huang, Jeff Shih-Chieh Chueh
Publikováno v:
Urological Science, Vol 35, Iss 1, Pp 3-8 (2024)
Primary aldosteronism (PA), the most important cause of secondary endocrine hypertension, is hallmarked by excessive aldosterone secretion. There were 2 subtypes of PA—unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia, whic
Externí odkaz:
https://doaj.org/article/9dbbf8a4f43d494f8ddcab1d613c23d0